Vosoritide for Short Stature in Turner Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vosoritide for Short Stature in Turner Syndrome — Stella

Recruiting

Back to Turner Syndrome trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Children's National Hospital, Washington D.C., District of Columbia

Key details

Phase

Safety & dosing

Sponsor

Roopa Kanakatti Shankar, MBBS, MS

Enrollment target

~20 participants

Started

April 2024

Primary completion

September 2026

Age range

3 Years – 11 Years

Sex

Female only

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov